Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1867553
PUBLISHER: QYResearch | PRODUCT CODE: 1867553
Medical Second Opinion - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
PUBLISHED:
PAGES: 124 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global market for Medical Second Opinion was estimated to be worth US$ 6973 million in 2024 and is forecast to a readjusted size of US$ 17948 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.
Medical Second Opinion refers to a professional healthcare service where a patient, after receiving an initial diagnosis or treatment recommendation, consults an independent, qualified medical expert for a reevaluation. This may include a review of diagnosis, therapeutic plan, or surgical necessity. The service is typically delivered through remote consultations, online platforms, or international collaborations, especially in cases involving critical illness, rare diseases, or complex interventions. It aims to reduce misdiagnosis, enhance treatment accuracy, and build patient confidence. With the advancement of telemedicine, global healthcare connectivity, and AI-driven diagnostics, Medical Second Opinion is emerging as a critical component in premium healthcare offerings, insurance services, and cross-border referral ecosystems.
As medical decisions become more complex, the market for Medical Second Opinion services is experiencing rapid growth. According to annual reports, global high-net-worth and middle-class populations are increasingly seeking access to premium healthcare resources, especially in oncology, cardiovascular diseases, and rare conditions where patients demand confirmation and optimized treatment plans. Insurance providers are embedding second opinion services into critical illness and health insurance products, improving customer engagement and loyalty. Governments in countries like the U.S., Germany, and Singapore have incorporated second opinions into reimbursement or legal frameworks, enhancing credibility. Meanwhile, the integration of AI-assisted diagnostics, international telemedicine platforms, and global medical expert networks has significantly improved the accessibility and accuracy of these services.
Despite growing interest, Medical Second Opinion services face systemic and operational barriers. Cross-border service delivery is complicated by diverse healthcare systems, lack of standardized medical records, and data interoperability issues. High-level medical expertise remains concentrated in a few top institutions, limiting supply-side scalability. In many regions, payment mechanisms are unclear, and insurance coverage is insufficient to support widespread adoption. Additionally, concerns about data privacy and regulatory compliance for cross-border data sharing pose legal risks. For emerging providers, building trust networks of qualified physicians, ensuring consistent service quality, and forming hospital partnerships are critical but challenging.
Driven by the rise of personalized medicine and patient empowerment, Medical Second Opinion services are evolving from a niche premium add-on to a standard component of clinical care. Integrated packages offering "diagnosis + expert review" are gaining popularity, particularly for cancers, cardiovascular, and neurological diseases. Digital health platforms and telemedicine providers are embedding second opinion modules into broader ecosystems that include AI imaging analysis, auto-structured medical records, and access to international experts. In fast-growing regions such as Asia and the Middle East, high-net-worth individuals and critical illness policyholders are fueling adoption, pushing the industry toward greater personalization, globalization, and platform-based models.
This report aims to provide a comprehensive presentation of the global market for Medical Second Opinion, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Second Opinion by region & country, by Type, and by Application.
The Medical Second Opinion market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Second Opinion.
Market Segmentation
By Company
- HCA Hospitals
- AXA PPP Healthcare
- Royal London Group
- Helsana Group
- Cleveland Clinic
- Amradnet
- Best Doctors
- Inova Care
- Toranomon Hospital
- Keio University Hospital
- Johns Hopkins Medicine
- Penn Medicine
- Oncology International Pvt. Ltd.
- GrandOpinion
- London Pain Clinic
- Mondial Assistance
- Medisense
- Medo Asia Sdn. Bhd.
Segment by Type
- Hospitals
- Medical Second Opinion Providing Companies
- Health Insurance Companies
Segment by Application
- Cancer
- Diabetes
- Cardiac Disorders
- Neurological Disorders
- Ocular Disorders
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Second Opinion company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Second Opinion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Second Opinion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Medical Second Opinion Product Introduction
- 1.2 Global Medical Second Opinion Market Size Forecast (2020-2031)
- 1.3 Medical Second Opinion Market Trends & Drivers
- 1.3.1 Medical Second Opinion Industry Trends
- 1.3.2 Medical Second Opinion Market Drivers & Opportunity
- 1.3.3 Medical Second Opinion Market Challenges
- 1.3.4 Medical Second Opinion Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Medical Second Opinion Players Revenue Ranking (2024)
- 2.2 Global Medical Second Opinion Revenue by Company (2020-2025)
- 2.3 Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Medical Second Opinion Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Medical Second Opinion
- 2.6 Medical Second Opinion Market Competitive Analysis
- 2.6.1 Medical Second Opinion Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Medical Second Opinion Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Hospitals
- 3.1.2 Medical Second Opinion Providing Companies
- 3.1.3 Health Insurance Companies
- 3.2 Global Medical Second Opinion Sales Value by Type
- 3.2.1 Global Medical Second Opinion Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Medical Second Opinion Sales Value, by Type (2020-2031)
- 3.2.3 Global Medical Second Opinion Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Cancer
- 4.1.2 Diabetes
- 4.1.3 Cardiac Disorders
- 4.1.4 Neurological Disorders
- 4.1.5 Ocular Disorders
- 4.1.6 Others
- 4.2 Global Medical Second Opinion Sales Value by Application
- 4.2.1 Global Medical Second Opinion Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Medical Second Opinion Sales Value, by Application (2020-2031)
- 4.2.3 Global Medical Second Opinion Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Medical Second Opinion Sales Value by Region
- 5.1.1 Global Medical Second Opinion Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Medical Second Opinion Sales Value by Region (2020-2025)
- 5.1.3 Global Medical Second Opinion Sales Value by Region (2026-2031)
- 5.1.4 Global Medical Second Opinion Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Medical Second Opinion Sales Value, 2020-2031
- 5.2.2 North America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Medical Second Opinion Sales Value, 2020-2031
- 5.3.2 Europe Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Medical Second Opinion Sales Value, 2020-2031
- 5.4.2 Asia Pacific Medical Second Opinion Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Medical Second Opinion Sales Value, 2020-2031
- 5.5.2 South America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Medical Second Opinion Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Medical Second Opinion Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Medical Second Opinion Sales Value, 2020-2031
- 6.3.2 United States Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Medical Second Opinion Sales Value, 2020-2031
- 6.4.2 Europe Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Medical Second Opinion Sales Value, 2020-2031
- 6.5.2 China Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Medical Second Opinion Sales Value, 2020-2031
- 6.6.2 Japan Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Medical Second Opinion Sales Value, 2020-2031
- 6.7.2 South Korea Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Medical Second Opinion Sales Value, 2020-2031
- 6.8.2 Southeast Asia Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Medical Second Opinion Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Medical Second Opinion Sales Value, 2020-2031
- 6.9.2 India Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Medical Second Opinion Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 HCA Hospitals
- 7.1.1 HCA Hospitals Profile
- 7.1.2 HCA Hospitals Main Business
- 7.1.3 HCA Hospitals Medical Second Opinion Products, Services and Solutions
- 7.1.4 HCA Hospitals Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.1.5 HCA Hospitals Recent Developments
- 7.2 AXA PPP Healthcare
- 7.2.1 AXA PPP Healthcare Profile
- 7.2.2 AXA PPP Healthcare Main Business
- 7.2.3 AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
- 7.2.4 AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.2.5 AXA PPP Healthcare Recent Developments
- 7.3 Royal London Group
- 7.3.1 Royal London Group Profile
- 7.3.2 Royal London Group Main Business
- 7.3.3 Royal London Group Medical Second Opinion Products, Services and Solutions
- 7.3.4 Royal London Group Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.3.5 Royal London Group Recent Developments
- 7.4 Helsana Group
- 7.4.1 Helsana Group Profile
- 7.4.2 Helsana Group Main Business
- 7.4.3 Helsana Group Medical Second Opinion Products, Services and Solutions
- 7.4.4 Helsana Group Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.4.5 Helsana Group Recent Developments
- 7.5 Cleveland Clinic
- 7.5.1 Cleveland Clinic Profile
- 7.5.2 Cleveland Clinic Main Business
- 7.5.3 Cleveland Clinic Medical Second Opinion Products, Services and Solutions
- 7.5.4 Cleveland Clinic Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.5.5 Cleveland Clinic Recent Developments
- 7.6 Amradnet
- 7.6.1 Amradnet Profile
- 7.6.2 Amradnet Main Business
- 7.6.3 Amradnet Medical Second Opinion Products, Services and Solutions
- 7.6.4 Amradnet Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.6.5 Amradnet Recent Developments
- 7.7 Best Doctors
- 7.7.1 Best Doctors Profile
- 7.7.2 Best Doctors Main Business
- 7.7.3 Best Doctors Medical Second Opinion Products, Services and Solutions
- 7.7.4 Best Doctors Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.7.5 Best Doctors Recent Developments
- 7.8 Inova Care
- 7.8.1 Inova Care Profile
- 7.8.2 Inova Care Main Business
- 7.8.3 Inova Care Medical Second Opinion Products, Services and Solutions
- 7.8.4 Inova Care Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.8.5 Inova Care Recent Developments
- 7.9 Toranomon Hospital
- 7.9.1 Toranomon Hospital Profile
- 7.9.2 Toranomon Hospital Main Business
- 7.9.3 Toranomon Hospital Medical Second Opinion Products, Services and Solutions
- 7.9.4 Toranomon Hospital Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.9.5 Toranomon Hospital Recent Developments
- 7.10 Keio University Hospital
- 7.10.1 Keio University Hospital Profile
- 7.10.2 Keio University Hospital Main Business
- 7.10.3 Keio University Hospital Medical Second Opinion Products, Services and Solutions
- 7.10.4 Keio University Hospital Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.10.5 Keio University Hospital Recent Developments
- 7.11 Johns Hopkins Medicine
- 7.11.1 Johns Hopkins Medicine Profile
- 7.11.2 Johns Hopkins Medicine Main Business
- 7.11.3 Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
- 7.11.4 Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.11.5 Johns Hopkins Medicine Recent Developments
- 7.12 Penn Medicine
- 7.12.1 Penn Medicine Profile
- 7.12.2 Penn Medicine Main Business
- 7.12.3 Penn Medicine Medical Second Opinion Products, Services and Solutions
- 7.12.4 Penn Medicine Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.12.5 Penn Medicine Recent Developments
- 7.13 Oncology International Pvt. Ltd.
- 7.13.1 Oncology International Pvt. Ltd. Profile
- 7.13.2 Oncology International Pvt. Ltd. Main Business
- 7.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
- 7.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.13.5 Oncology International Pvt. Ltd. Recent Developments
- 7.14 GrandOpinion
- 7.14.1 GrandOpinion Profile
- 7.14.2 GrandOpinion Main Business
- 7.14.3 GrandOpinion Medical Second Opinion Products, Services and Solutions
- 7.14.4 GrandOpinion Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.14.5 GrandOpinion Recent Developments
- 7.15 London Pain Clinic
- 7.15.1 London Pain Clinic Profile
- 7.15.2 London Pain Clinic Main Business
- 7.15.3 London Pain Clinic Medical Second Opinion Products, Services and Solutions
- 7.15.4 London Pain Clinic Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.15.5 London Pain Clinic Recent Developments
- 7.16 Mondial Assistance
- 7.16.1 Mondial Assistance Profile
- 7.16.2 Mondial Assistance Main Business
- 7.16.3 Mondial Assistance Medical Second Opinion Products, Services and Solutions
- 7.16.4 Mondial Assistance Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.16.5 Mondial Assistance Recent Developments
- 7.17 Medisense
- 7.17.1 Medisense Profile
- 7.17.2 Medisense Main Business
- 7.17.3 Medisense Medical Second Opinion Products, Services and Solutions
- 7.17.4 Medisense Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.17.5 Medisense Recent Developments
- 7.18 Medo Asia Sdn. Bhd.
- 7.18.1 Medo Asia Sdn. Bhd. Profile
- 7.18.2 Medo Asia Sdn. Bhd. Main Business
- 7.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
- 7.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million) & (2020-2025)
- 7.18.5 Medo Asia Sdn. Bhd. Recent Developments
8 Industry Chain Analysis
- 8.1 Medical Second Opinion Industrial Chain
- 8.2 Medical Second Opinion Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Medical Second Opinion Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Medical Second Opinion Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Medical Second Opinion Market Trends
- Table 2. Medical Second Opinion Market Drivers & Opportunity
- Table 3. Medical Second Opinion Market Challenges
- Table 4. Medical Second Opinion Market Restraints
- Table 5. Global Medical Second Opinion Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Medical Second Opinion Revenue Market Share by Company (2020-2025)
- Table 7. Key Companies Medical Second Opinion Manufacturing Base Distribution and Headquarters
- Table 8. Key Companies Medical Second Opinion Product Type
- Table 9. Key Companies Time to Begin Mass Production of Medical Second Opinion
- Table 10. Global Medical Second Opinion Companies Market Concentration Ratio (CR5 and HHI)
- Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Second Opinion as of 2024)
- Table 12. Mergers & Acquisitions, Expansion Plans
- Table 13. Global Medical Second Opinion Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 14. Global Medical Second Opinion Sales Value by Type (2020-2025) & (US$ Million)
- Table 15. Global Medical Second Opinion Sales Value by Type (2026-2031) & (US$ Million)
- Table 16. Global Medical Second Opinion Sales Market Share in Value by Type (2020-2025)
- Table 17. Global Medical Second Opinion Sales Market Share in Value by Type (2026-2031)
- Table 18. Global Medical Second Opinion Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 19. Global Medical Second Opinion Sales Value by Application (2020-2025) & (US$ Million)
- Table 20. Global Medical Second Opinion Sales Value by Application (2026-2031) & (US$ Million)
- Table 21. Global Medical Second Opinion Sales Market Share in Value by Application (2020-2025)
- Table 22. Global Medical Second Opinion Sales Market Share in Value by Application (2026-2031)
- Table 23. Global Medical Second Opinion Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 24. Global Medical Second Opinion Sales Value by Region (2020-2025) & (US$ Million)
- Table 25. Global Medical Second Opinion Sales Value by Region (2026-2031) & (US$ Million)
- Table 26. Global Medical Second Opinion Sales Value by Region (2020-2025) & (%)
- Table 27. Global Medical Second Opinion Sales Value by Region (2026-2031) & (%)
- Table 28. Key Countries/Regions Medical Second Opinion Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 29. Key Countries/Regions Medical Second Opinion Sales Value, (2020-2025) & (US$ Million)
- Table 30. Key Countries/Regions Medical Second Opinion Sales Value, (2026-2031) & (US$ Million)
- Table 31. HCA Hospitals Basic Information List
- Table 32. HCA Hospitals Description and Business Overview
- Table 33. HCA Hospitals Medical Second Opinion Products, Services and Solutions
- Table 34. Revenue (US$ Million) in Medical Second Opinion Business of HCA Hospitals (2020-2025)
- Table 35. HCA Hospitals Recent Developments
- Table 36. AXA PPP Healthcare Basic Information List
- Table 37. AXA PPP Healthcare Description and Business Overview
- Table 38. AXA PPP Healthcare Medical Second Opinion Products, Services and Solutions
- Table 39. Revenue (US$ Million) in Medical Second Opinion Business of AXA PPP Healthcare (2020-2025)
- Table 40. AXA PPP Healthcare Recent Developments
- Table 41. Royal London Group Basic Information List
- Table 42. Royal London Group Description and Business Overview
- Table 43. Royal London Group Medical Second Opinion Products, Services and Solutions
- Table 44. Revenue (US$ Million) in Medical Second Opinion Business of Royal London Group (2020-2025)
- Table 45. Royal London Group Recent Developments
- Table 46. Helsana Group Basic Information List
- Table 47. Helsana Group Description and Business Overview
- Table 48. Helsana Group Medical Second Opinion Products, Services and Solutions
- Table 49. Revenue (US$ Million) in Medical Second Opinion Business of Helsana Group (2020-2025)
- Table 50. Helsana Group Recent Developments
- Table 51. Cleveland Clinic Basic Information List
- Table 52. Cleveland Clinic Description and Business Overview
- Table 53. Cleveland Clinic Medical Second Opinion Products, Services and Solutions
- Table 54. Revenue (US$ Million) in Medical Second Opinion Business of Cleveland Clinic (2020-2025)
- Table 55. Cleveland Clinic Recent Developments
- Table 56. Amradnet Basic Information List
- Table 57. Amradnet Description and Business Overview
- Table 58. Amradnet Medical Second Opinion Products, Services and Solutions
- Table 59. Revenue (US$ Million) in Medical Second Opinion Business of Amradnet (2020-2025)
- Table 60. Amradnet Recent Developments
- Table 61. Best Doctors Basic Information List
- Table 62. Best Doctors Description and Business Overview
- Table 63. Best Doctors Medical Second Opinion Products, Services and Solutions
- Table 64. Revenue (US$ Million) in Medical Second Opinion Business of Best Doctors (2020-2025)
- Table 65. Best Doctors Recent Developments
- Table 66. Inova Care Basic Information List
- Table 67. Inova Care Description and Business Overview
- Table 68. Inova Care Medical Second Opinion Products, Services and Solutions
- Table 69. Revenue (US$ Million) in Medical Second Opinion Business of Inova Care (2020-2025)
- Table 70. Inova Care Recent Developments
- Table 71. Toranomon Hospital Basic Information List
- Table 72. Toranomon Hospital Description and Business Overview
- Table 73. Toranomon Hospital Medical Second Opinion Products, Services and Solutions
- Table 74. Revenue (US$ Million) in Medical Second Opinion Business of Toranomon Hospital (2020-2025)
- Table 75. Toranomon Hospital Recent Developments
- Table 76. Keio University Hospital Basic Information List
- Table 77. Keio University Hospital Description and Business Overview
- Table 78. Keio University Hospital Medical Second Opinion Products, Services and Solutions
- Table 79. Revenue (US$ Million) in Medical Second Opinion Business of Keio University Hospital (2020-2025)
- Table 80. Keio University Hospital Recent Developments
- Table 81. Johns Hopkins Medicine Basic Information List
- Table 82. Johns Hopkins Medicine Description and Business Overview
- Table 83. Johns Hopkins Medicine Medical Second Opinion Products, Services and Solutions
- Table 84. Revenue (US$ Million) in Medical Second Opinion Business of Johns Hopkins Medicine (2020-2025)
- Table 85. Johns Hopkins Medicine Recent Developments
- Table 86. Penn Medicine Basic Information List
- Table 87. Penn Medicine Description and Business Overview
- Table 88. Penn Medicine Medical Second Opinion Products, Services and Solutions
- Table 89. Revenue (US$ Million) in Medical Second Opinion Business of Penn Medicine (2020-2025)
- Table 90. Penn Medicine Recent Developments
- Table 91. Oncology International Pvt. Ltd. Basic Information List
- Table 92. Oncology International Pvt. Ltd. Description and Business Overview
- Table 93. Oncology International Pvt. Ltd. Medical Second Opinion Products, Services and Solutions
- Table 94. Revenue (US$ Million) in Medical Second Opinion Business of Oncology International Pvt. Ltd. (2020-2025)
- Table 95. Oncology International Pvt. Ltd. Recent Developments
- Table 96. GrandOpinion Basic Information List
- Table 97. GrandOpinion Description and Business Overview
- Table 98. GrandOpinion Medical Second Opinion Products, Services and Solutions
- Table 99. Revenue (US$ Million) in Medical Second Opinion Business of GrandOpinion (2020-2025)
- Table 100. GrandOpinion Recent Developments
- Table 101. London Pain Clinic Basic Information List
- Table 102. London Pain Clinic Description and Business Overview
- Table 103. London Pain Clinic Medical Second Opinion Products, Services and Solutions
- Table 104. Revenue (US$ Million) in Medical Second Opinion Business of London Pain Clinic (2020-2025)
- Table 105. London Pain Clinic Recent Developments
- Table 106. Mondial Assistance Basic Information List
- Table 107. Mondial Assistance Description and Business Overview
- Table 108. Mondial Assistance Medical Second Opinion Products, Services and Solutions
- Table 109. Revenue (US$ Million) in Medical Second Opinion Business of Mondial Assistance (2020-2025)
- Table 110. Mondial Assistance Recent Developments
- Table 111. Medisense Basic Information List
- Table 112. Medisense Description and Business Overview
- Table 113. Medisense Medical Second Opinion Products, Services and Solutions
- Table 114. Revenue (US$ Million) in Medical Second Opinion Business of Medisense (2020-2025)
- Table 115. Medisense Recent Developments
- Table 116. Medo Asia Sdn. Bhd. Basic Information List
- Table 117. Medo Asia Sdn. Bhd. Description and Business Overview
- Table 118. Medo Asia Sdn. Bhd. Medical Second Opinion Products, Services and Solutions
- Table 119. Revenue (US$ Million) in Medical Second Opinion Business of Medo Asia Sdn. Bhd. (2020-2025)
- Table 120. Medo Asia Sdn. Bhd. Recent Developments
- Table 121. Key Raw Materials Lists
- Table 122. Raw Materials Key Suppliers Lists
- Table 123. Medical Second Opinion Downstream Customers
- Table 124. Medical Second Opinion Distributors List
- Table 125. Research Programs/Design for This Report
- Table 126. Key Data Information from Secondary Sources
- Table 127. Key Data Information from Primary Sources
List of Figures
- Figure 1. Medical Second Opinion Product Picture
- Figure 2. Global Medical Second Opinion Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Medical Second Opinion Sales Value (2020-2031) & (US$ Million)
- Figure 4. Medical Second Opinion Report Years Considered
- Figure 5. Global Medical Second Opinion Players Revenue Ranking (2024) & (US$ Million)
- Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Medical Second Opinion Revenue in 2024
- Figure 7. Medical Second Opinion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 8. Hospitals Picture
- Figure 9. Medical Second Opinion Providing Companies Picture
- Figure 10. Health Insurance Companies Picture
- Figure 11. Global Medical Second Opinion Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 12. Global Medical Second Opinion Sales Value Market Share by Type, 2024 & 2031
- Figure 13. Product Picture of Cancer
- Figure 14. Product Picture of Diabetes
- Figure 15. Product Picture of Cardiac Disorders
- Figure 16. Product Picture of Neurological Disorders
- Figure 17. Product Picture of Ocular Disorders
- Figure 18. Product Picture of Others
- Figure 19. Global Medical Second Opinion Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 20. Global Medical Second Opinion Sales Value Market Share by Application, 2024 & 2031
- Figure 21. North America Medical Second Opinion Sales Value (2020-2031) & (US$ Million)
- Figure 22. North America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- Figure 23. Europe Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 24. Europe Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- Figure 25. Asia Pacific Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 26. Asia Pacific Medical Second Opinion Sales Value by Region (%), 2024 VS 2031
- Figure 27. South America Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 28. South America Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- Figure 29. Middle East & Africa Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 30. Middle East & Africa Medical Second Opinion Sales Value by Country (%), 2024 VS 2031
- Figure 31. Key Countries/Regions Medical Second Opinion Sales Value (%), (2020-2031)
- Figure 32. United States Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 33. United States Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 34. United States Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 35. Europe Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 36. Europe Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 37. Europe Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 38. China Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 39. China Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 40. China Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 41. Japan Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 42. Japan Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 43. Japan Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 44. South Korea Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 45. South Korea Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 46. South Korea Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 47. Southeast Asia Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 48. Southeast Asia Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 49. Southeast Asia Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 50. India Medical Second Opinion Sales Value, (2020-2031) & (US$ Million)
- Figure 51. India Medical Second Opinion Sales Value by Type (%), 2024 VS 2031
- Figure 52. India Medical Second Opinion Sales Value by Application (%), 2024 VS 2031
- Figure 53. Medical Second Opinion Industrial Chain
- Figure 54. Medical Second Opinion Manufacturing Cost Structure
- Figure 55. Channels of Distribution (Direct Sales, and Distribution)
- Figure 56. Bottom-up and Top-down Approaches for This Report
- Figure 57. Data Triangulation
- Figure 58. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.